Search company, investor...

Alibaba Health

alihealth.cn

Founded Year

2014

Stage

Corporate Majority - P2P | IPO

Market Cap

99.64B

About Alibaba Health

Alibaba Health (HKG: 0241) provides comprehensive online solutions that facilitate the cross-regional sharing of social healthcare resources, enhance the efficiency of medical care, and promote easier access to medicine. The company's business focus is on pharmaceutical e-commerce, intelligent medicine, and product tracking. It serves customers operating in the healthcare sector as well as individuals. The company was founded in 2014 and is based in Beijing, Beijing. It operates as the healthcare subsidiary of Alibaba Group.

Headquarters Location

Block 1, Block B, Greenfield Center Hongtai East Street, Chaoyang District

Beijing, Beijing, 100102,

China

+86 010-58259000

Missing: Alibaba Health's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Alibaba Health's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Alibaba Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Alibaba Health in 1 CB Insights research brief, most recently on Jun 24, 2020.

Latest Alibaba Health News

Alibaba Health Shares Rise After Swinging to Profit in First Half

Nov 29, 2022

11/28/2022 | 10:25pm EST Message : By Clarence Leong Shares of Alibaba Health Information Technology Ltd. rose strongly after it swung to a profit in its fiscal first half. Alibaba Health's Hong Kong-listed stock gained 9.2% to 6.07 Hong Kong dollars (US$0.78) on Tuesday, paring year-to-date losses to 7.9%. The stock outperformed the Hang Seng Tech index's 4.7% rise and the benchmark Hang Seng Index's 3.5% increase. The company said late Monday that it achieved a turnaround in its first half ended Sept. 30, posting a net profit of 160.7 million yuan (US$22.3 million), compared with a net loss of CNY231.8 million a year earlier. Revenue for the period increased 23% from the year-earlier period to CNY11.50 billion, driven by its pharmaceutical direct sales business, which grew 24%, it said. Gross profit margin for that segment improved, thanks to stronger bargaining and digital-marketing capabilities, although overall gross profit margin was flat at 20%, Alibaba Health said. The company said its pharmaceutical e-commerce platform served 27,000 merchants at the end of the period, up by 2,000 from a year earlier, while annual active consumers of its direct online stores rose more than 30 million to above 120 million over the same period. Write to Clarence Leong at clarence.leong@wsj.com (END) Dow Jones Newswires

Alibaba Health Frequently Asked Questions (FAQ)

  • When was Alibaba Health founded?

    Alibaba Health was founded in 2014.

  • Where is Alibaba Health's headquarters?

    Alibaba Health's headquarters is located at Block 1, Block B, Greenfield Center, Beijing.

  • What is Alibaba Health's latest funding round?

    Alibaba Health's latest funding round is Corporate Majority - P2P.

  • Who are the investors of Alibaba Health?

    Investors of Alibaba Health include Alibaba Group and CITIC 21CN.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.